Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes: A Randomized Controlled Trial of SHIFT2

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also include a caregiver. Results from this study will inform clinical recommendations regarding self-management best practices for AYAs with T1D prior to transitioning to adult medical care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

⁃ AYA:

• Type 1 Diabetes diagnosis for at least 1 year (as documented in medical record)

• 16-22 years old

• English speaking

• Children's Hospital of Richmond patient (Division of Pediatric Endocrinology)

• must have a caregiver willing to participate

⁃ Caregiver:

• Age greater than 18 years

• Provides care to AYA and willing to participate

Locations
United States
Virginia
Virginia Commonwealth University
RECRUITING
Richmond
Contact Information
Primary
Sarah Farthing
sarah.malone@vcuhealth.org
804-527-4756
Backup
Laura Caccavale
laura.caccavale@vcuhealth.org
804-527-4756
Time Frame
Start Date: 2023-08-24
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 115
Treatments
Experimental: Group A: SHIFT2
Adolescents and young adults will engage in routine medical visits and attend 6 sessions (1x/month) focused on transition preparation and diabetes management with a transition coach and will receive bi-weekly messages during these 6-months that encourage self-management behaviors.~Parents will attend 2 sessions (month 1 and 6) with a transition coach and will receive materials, complementing their child's lesson, 1x/month for months 2-5 that focus on transition their role and supporting their child's diabetes management.
Placebo_comparator: Group B: TAU+/Control
Participants will engage in routine medical visits and will receive education materials monthly (1x/month) regarding healthcare transition and diabetes management.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Virginia Commonwealth University

This content was sourced from clinicaltrials.gov